Korean J Gastroenterol.  2016 Apr;67(4):227-229. 10.4166/kjg.2016.67.4.227.

Is Rectal Indomethacin Sufficient to Prevent Pancreatitis after Endoscopic Retrograde Cholangiopancreatography?

• Choi HJ

• KMID: 2373431
• DOI: http://doi.org/10.4166/kjg.2016.67.4.227

Abstract

No abstract available.

Reference

References

1. Levenick JM, Gordon SR, Fadden LL, et al. Rectal indomethacin does not prevent post-ERCP pancreatitis in consecutive patients. Gastroenterology. 2016; 150:911–917.

2. Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996; 335:909–918.

3. Kochar B, Akshintala VS, Afghani E, et al. Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest Endosc. 2015; 81:143–149.

4. Mazaki T, Masuda H, Takayama T. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and metaanalysis. Endoscopy. 2010; 42:842–853.

5. Choudhary A, Bechtold ML, Arif M, et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a metaanalysis and systematic review. Gastrointest Endosc. 2011; 73:275–282.

6. Sofuni A, Maguchi H, Mukai T, et al. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients. Clin Gastroenterol Hepatol. 2011; 9:851–858.

7. Elmunzer BJ, Scheiman JM, Lehman GA, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012; 366:1414–1422.

8. Ahmad D, Lopez KT, Esmadi MA, et al. The effect of indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a metaanalysis. Pancreas. 2014; 43:338–342.

9. Sethi S, Sethi N, Wadhwa V, Garud S, Brown A. A metaanalysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Pancreas. 2014; 43:190–197.

10. Yuhara H, Ogawa M, Kawaguchi Y, Igarashi M, Shimosegawa T, Mine T. Pharmacologic prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: protease inhibitors and NSAIDs in a metaanalysis. J Gastroenterol. 2014; 49:388–399.

11. Kubiliun NM, Adams MA, Akshintala VS, et al. Evaluation of pharmacologic prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a systematic review. Clin Gastroenterol Hepatol. 2015; 13:1231–1239.

12. Dumonceau JM, Andriulli A, Elmunzer BJ, et al. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) guideline–updated June 2014. Endoscopy. 2014; 46:799–815.

13. Freeman ML, Kozarek RA. Take 2 indomethacin (suppositories) and call me in the morning? The role of nonsteroidal anti-inflammatory drugs in protection against post-endoscopic retrograde cholangiopancreatography pancreatitis. Gastroenterology. 2016; 150:805–808.

14. Arain MA, Freeman ML. Pancreatic stent placement remains a cornerstone of prevention of post-ERCP pancreatitis, but it requires specialized techniques. Gastrointest Endosc. 2015; 81:156–158.